Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II study of 611 in chronic rhinosinusitis with nasal polyps (CRSwNP)
CTR20231233Phase 2Active
- Sponsor
- 3S Guojian Pharmaceutical
- Start
- Jul 2023
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of SSGJ-611 in chronic rhinosinusitis with nasal polyps (CRSwNP), sponsored by 3S Guojian Pharmaceutical. Started Jul 2023; status: active.
02
Drugs
SSGJ-611
03
Conditions
chronic rhinosinusitis with nasal polyps (CRSwNP)
Beyond the preview
Go deeper on CTR20231233.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20231233.